Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema ; volume:12 ; number:1 ; day:23 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (23.6.2022), 1-13, 12.2022

Creator
Tatsumi, Tomoaki
Takatsuna, Yoko
Oshitari, Toshiyuki
Kaiho, Tomomi
Kawasaki, Yohei
Shiko, Yuki
Sugawara, Takeshi
Baba, Takayuki
Yamamoto, Shuichi
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-022-14444-y
URN
urn:nbn:de:101:1-2022081600050741329135
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Tatsumi, Tomoaki
  • Takatsuna, Yoko
  • Oshitari, Toshiyuki
  • Kaiho, Tomomi
  • Kawasaki, Yohei
  • Shiko, Yuki
  • Sugawara, Takeshi
  • Baba, Takayuki
  • Yamamoto, Shuichi
  • SpringerLink (Online service)

Other Objects (12)

Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema

Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy

Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study

Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study

Full thickness macular hole case after intravitreal aflibercept treatment

Full thickness macular hole case after intravitreal aflibercept treatment

Result of intravitreal aflibercept injection for myopic choroidal neovascularization

Result of intravitreal aflibercept injection for myopic choroidal neovascularization

Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema

Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema

Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema

Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization

Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps

Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps

Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema

Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes

Related objects